Nevro Names Kevin Thornal As Its New CEO; Investors Remain Disappointed In Results

 
• By Reed Miller

Thornal will replace Keith Grossman who is retiring. Investors and analysts hope Thornal will help the spinal cord stimulation company reach profitability by growing its “core” chronic pain business.

low back pain
• Source: Alamy

More from Leadership

More from Medtech Insight